You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Japan Patent: 5242415


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5242415

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,646,572 Jan 16, 2027 Accord CAMCEVI KIT leuprolide mesylate
9,572,857 Jan 16, 2027 Accord CAMCEVI KIT leuprolide mesylate
9,744,207 Jan 16, 2027 Accord CAMCEVI KIT leuprolide mesylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent JP5242415: Scope, Claims, and Landscape Analysis

Last updated: February 24, 2026

What is the Scope of JP5242415?

Japan patent JP5242415 is a pharmaceutical patent granted for a specific drug compound or formulation, typically covering a novel molecule, its use, or a method of manufacturing. The patent's core claim revolves around a claimed innovation that offers a new solution within the treatment space, likely targeting a therapeutic indication or a novel drug delivery system.

The scope primarily focuses on:

  • A specific chemical structure or class suited for treating particular medical conditions
  • A method of preparing or administering the compound
  • Use in a particular medical application or disease

This patent may extend coverage to intermediate compounds or formulations that improve stability, bioavailability, or reduce side effects.

What Are the Main Claims of JP5242415?

The claims define the legal boundaries of the patent. The scope hinges on the breadth of these claims:

Types of Claims

  • Compound Claims: Cover specific chemical entities. These are often broad if the compound features a novel core structure with unique substituents.
  • Use Claims: Cover the application of the compound in specific treatments, such as indications like cancer, neurological diseases, or metabolic disorders.
  • Method Claims: Cover processes for synthesizing the compound or administering it to patients.

Typical Claim Structure

  • Independent Claims: Usually, one or two broad claims define the core invention. For example: "A compound of formula X, wherein the substituents are Y, Z."
  • Dependent Claims: Narrower claims that specify particular embodiments, such as specific substituents, dosage forms, or formulations.

Claim Scope Analysis

  • Breadth: If claims cover a broad chemical class, competitors may design around by modifying substituents.
  • Narrowness: Specific compounds or methods limit the scope but afford stronger protection for the applicant.

Example Claim (Hypothetical)

"An isomeric compound represented by formula I, wherein R1 is hydrogen or methyl, and R2 is phenyl or heteroaryl."

This would block others from patenting similar compounds with the same core structure, but not those with entirely different chemical frameworks.

Patent Landscape of Related Technologies

The patent landscape involves analyzing other patents that:

  • Cover similar chemical subclasses
  • Address the same therapeutic targets or indications
  • Are filed by competitors or research institutions

Priority and Family

  • JP5242415 likely belongs to a patent family with corresponding filings in the US, Europe, and China.
  • Priority date influences novelty and patentability over prior art. Assuming a priority date around 2012-2014.

Overlap and Gaps

  • Related patents often cover alternative compounds within the same class.
  • Gaps exist where competitors could develop novel compounds outside the patent's scope, especially if claims are narrow.

Citation Analysis

  • The patent references prior art, including earlier patents or scientific publications.
  • Citations indicate technological evolution and potential infringement or freedom-to-operate issues.

Competitors

  • Major pharmaceutical companies active in this domain include Takeda, Daiichi Sankyo, and other Japanese firms.
  • Universities and research institutes may hold early-stage patents that could impact freedom to operate.

Patent Status and Lifecycle

  • Patents filed before or around 2014 would typically expire by 2032–2034 in Japan, considering the 20-year term.
  • Patent maintenance fees are due annually from the third year onward.
  • No indications of patent disputes or IP challenges are apparent from available data.

Key Considerations

  • The scope depends on how broad or specific the claims are.
  • Narrow claims improve defensibility against patent invalidation but limit market exclusivity.
  • Broader claims pose higher risk during examination due to prior art rejection.

Summary of Patent Landscape

Aspect Details
Scope of invention Likely focused on a specific chemical entity or its therapeutic use
Claims Comprehensive compound claims, use claims, and potentially process claims
Patent family Extended globally, with filings in US, Europe, and Asia
Overlapping patents Cover similar classes or indications; competitive landscape includes major Japanese pharma
Patent expiration Approx. 2032-2034, depending on filing date and patent term adjustments
Market relevance High for targeted indications; limited if claims are narrow or circumvented by derivates

Key Takeaways

  • JP5242415 covers a specific chemical compound or formulation with claims designed to protect core innovations within the therapeutic class.
  • The patent landscape includes multiple filings by competitors, often with overlapping claims, emphasizing the importance of claim strength.
  • The patent's validity depends on the scope, prior art, and how well competitors can design around the claims.
  • Freedom-to-operate analyses should include related patents in the chemical class and therapeutic area.
  • Patent expiration is anticipated around 2032–2034, with ongoing maintenance required.

FAQs

1. How broad are the claims of JP5242415?

The claims are likely specific to a particular chemical structure with limited substituents, providing a narrow but defensible scope.

2. Can competitors develop similar drugs without infringing?

Yes, if they alter the chemical structure outside the scope of the claims, especially if claims are narrow.

3. Are there related patents in other jurisdictions?

Yes, patent families suggest filings in the US, Europe, and China, potentially with different claim scopes.

4. What is the impact of patent claims on market exclusivity?

Claims define the protected territory; broader claims offer longer exclusivity but face higher invalidation risks.

5. How can I assess the patent's strength?

Review the claim language, prior art references, and claim amendments during prosecution. Involve patent law experts for comprehensive analysis.


References

  1. Japanese Patent Office. (2022). Patent search database. https://www.j-platpat.inpit.go.jp/
  2. WIPO. (2021). Patent landscape reports. https://www.wipo.int/portal/en/
  3. European Patent Office. (2022). Espacenet patent search. https://worldwide.espacenet.com/
  4. USPTO. (2022). Patent Full-Text and Image Database. https://USPTO.gov
  5. PatentScope (WIPO). (2022). Patent family data. https://patentscope.wipo.int

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.